250:
188:
129:
63:
22:
490:-member dealer. In 1995, Paramount Capital Investments LLC, a merchant and investment bank, was founded. Paramount Capital Asset Management, Inc., owned by Rosenwald, managed the investments of several funds specializing in the technology and biotechnology sectors since 1994. Rosenwald also serves as a member of the Columbia-Presbyterian
483:
the firm was shut down. Rosenwald headed a team of three physician-financiers who searched in the medical community for the latest developments that could be marketed with the help of private investment. They got in touch with hospitals, medical schools, pharmaceutical companies, universities, scientific firms and research groups.
482:
In 1988, Lindsay A. Rosenwald became a managing director of corporate finance for D.H. Blair & Co., a privately owned investment firm headed by J. Morton Davis. D.H. Blair underwrote hundreds of companies, many in the biotechnology industry. Several D.H. Blair brokers were indicted for fraud, and
519:
In addition to his activities, which have provided capital and funding to many portfolio companies, Rosenwald also started the
Rosenwald Foundation. This nonprofit organization has provided millions of dollars to support various scientific and medical education institutions.
473:
at their School of
Medicine. After graduating from Temple in 1983, Rosenwald interned at Abington Medical Hospital and remained in private medical practice until 1986. At that time, he moved to Wall Street to serve as a physician and financial analyst.
425:, a routinely fatal disease. This medicine has cured many thousands of incurable patients over the last decade, marking a significant change to how this disease is treated. One of his start-ups also developed a
501:' 100 Molecular Millionaires. Since 2002, Rosenwald was in the board of directors for Keryx Biopharmaceuticals, Inc., which he resigned in 2006 to devote more time to the biotechnology market.
606:
669:
957:
850:
821:
778:
516:
treatment and therapy but was so promising that
Johnson & Johnson bid & purchased the company in a "short-term merger" for approximately $ 1 billion.
656:
993:
487:
695:
486:
In 1991, Rosenwald founded
Paramount Bio Capital, where he dealt with the fields of bioresearch and biotechnology. Since 1992, he has become a
729:
446:
213:
35:
531:. This company specializes in healthcare and life sciences investments and consulting. In October 2010, he invested in securities in
310:
292:
231:
169:
110:
49:
273:
260:
202:
147:
92:
73:
937:"National Holdings Corporation Completes Equity Financing Led By OpusPoint Partners; Parties To Enter Into Strategic Alliance"
854:
825:
782:
607:"Lindsay Rosenwald Is The Executive Chairman of Fortress Biotech, Inc. (NASDAQ:FBIO) And They Just Picked Up 18% More Shares"
462:
343:
720:
Finance Club, Harvard
University. Graduate School of Business Administration. Career Resources Center (August 28, 2008).
724:. the University of California. Graduate School of Business Administration, Harvard University, 1990. pp. 35, 123.
422:
410:
458:
469:. Then he worked as an independent management consultant for healthcare companies from 1977 to 1979 before entering
532:
936:
998:
498:
88:
429:
medicine. That company acquired $ 1 billion after Phase 2 studies. Other approved medicines include meds for
139:
915:
631:
988:
151:
41:
524:
983:
505:
509:
389:
897:
739:
528:
392:
198:
725:
560:
470:
347:
209:
795:
552:
887:
466:
400:
396:
751:
513:
491:
426:
764:
377:
84:
807:
977:
901:
430:
385:
381:
142:
or has been extensively edited by the subject or by someone connected to the subject
434:
338:
564:
504:
Cougar
Biotechnology, another company founded by Rosenwald, was purchased by
584:
512:. This drug was not yet in phase III clinical trials for its application in
442:
406:
461:, located in southeast Pennsylvania, in 1973 and went on to graduate from
892:
875:
438:
851:"Molecular millionaires Interneuron executives top Massachusetts list"
418:
414:
779:"Never Mind the $ 100 M.: Doc Gets $ 75K in Rent for 15 CPW Duplex"
409:
his companies developed have been approved by the United States
822:"Biotechnology Bay State has share of 'Molecular Millionaires'"
243:
181:
122:
56:
15:
796:
http://ps.cpmc.columbia.edu/annual/docs/annualreport01.pdf
388:
industry investor. He is the co-founder of the healthcare
722:
Investment banking. Harvard
Business School career guide
465:
with a major in
Finance and Economy in 1977, graduating
798:
Columbia
UniversityCollege of Physicians & Surgeons
632:"J&J Buys Cougar Biotechnology to Add Cancer Drugs"
268:
80:
781:(Press release). The New York Observer. Archived from
765:
https://www.sec.gov/comments/s7-08-09/s70809-4614.pdf
91:, and by adding encyclopedic content written from a
808:
http://nyp.org/pdf/2005-2006_3_facts_financials.pdf
353:
337:
332:
325:
696:"INVESTING; A Doctor's Favorite Medical Start-Ups"
853:(Press release). The Boston Globe. Archived from
824:(Press release). The Boston Globe. Archived from
497:Rosenwald was number one in the 2002 edition of
150:policy. There may be relevant discussion on the
810:NewYork-Presbyterian Hospital Advisory Councils
670:"Careers; Gaining New Perspectives On Medicine"
146:It may need editing to conform to Knowledge's
849:Ronald Rosenberg, Globe Staff (Apr 9, 1997).
277:that contextualizes different points of view.
263:to certain ideas, incidents, or controversies
8:
216:of quality, and to make it neutral in tone.
50:Learn how and when to remove these messages
668:Elizabeth M. Fowler (September 25, 1990).
322:
891:
413:as well as in foreign countries, such as
395:. Rosenwald has created and sold several
311:Learn how and when to remove this message
293:Learn how and when to remove this message
232:Learn how and when to remove this message
170:Learn how and when to remove this message
111:Learn how and when to remove this message
543:
535:purchasing approximately 23.6% of NHC.
747:
737:
72:contains content that is written like
767:US Securities and Exchange Commission
694:Lawrence J. DeMaria (June 26, 1988).
7:
447:infant respiratory distress syndrome
376:Lindsay A. Rosenwald is an American
657:The New York Times: Business People
399:companies. In 2013 he established
14:
960:. finance.yahoo.com. May 26, 2011
31:This article has multiple issues.
994:Smeal College of Business alumni
421:. One medicine was approved for
248:
186:
127:
61:
20:
39:or discuss these issues on the
820:Brian O'Neill (Apr 21, 1999).
777:Max Abelson (April 14, 2009).
1:
636:Lisa Rapaport and David Olmos
551:Barbanel, Josh (2008-05-25).
533:National Holdings Corporation
527:founded a new company called
463:Pennsylvania State University
344:Pennsylvania State University
916:"OpusPoint Partners History"
423:acute promyelocytic leukemia
411:Food and Drug Administration
459:Abington Senior High School
1015:
958:"Ventrus Biosciences Inc"
939:. reuters.com. 6 Oct 2010
638:. Bloomberg. May 22, 2009
585:"OpusPoint Partners Team"
457:Rosenwald graduated from
370:
553:"Great Views, Priceless"
508:in 2009 based solely on
499:Genetic Engineering News
918:. opuspointpartners.com
523:In 2009, Rosenwald and
197:may be written from a
506:Johnson & Johnson
271:by rewriting it in a
203:neutral point of view
148:neutral point of view
93:neutral point of view
893:10.1038/nbt1206-1602
880:Nature Biotechnology
587:. OpusPoint Partners
510:abiraterone acetate
393:Opus Point Partners
390:private equity firm
199:fan's point of view
85:promotional content
886:(12): 1602. 2006.
785:on April 17, 2009.
750:has generic name (
700:The New York Times
674:The New York Times
557:The New York Times
529:OpusPoint Partners
494:Advisory Counsel.
87:and inappropriate
731:978-0-87584-223-3
471:Temple University
374:
373:
348:Temple University
327:Lindsay Rosenwald
321:
320:
313:
303:
302:
295:
257:This article may
242:
241:
234:
180:
179:
172:
121:
120:
113:
54:
1006:
999:Biotechnologists
969:
968:
966:
965:
954:
948:
947:
945:
944:
933:
927:
926:
924:
923:
912:
906:
905:
895:
872:
866:
865:
863:
862:
846:
840:
839:
834:
833:
817:
811:
805:
799:
793:
787:
786:
774:
768:
762:
756:
755:
749:
745:
743:
735:
717:
711:
710:
708:
707:
691:
685:
684:
682:
681:
665:
659:
654:
648:
647:
645:
643:
628:
622:
621:
619:
618:
603:
597:
596:
594:
592:
581:
575:
574:
572:
571:
548:
525:Michael S. Weiss
467:Beta Gamma Sigma
401:Fortress Biotech
397:biotechnological
333:Personal details
323:
316:
309:
298:
291:
287:
284:
278:
274:balanced fashion
252:
251:
244:
237:
230:
226:
223:
217:
212:to conform to a
201:, rather than a
190:
189:
182:
175:
168:
164:
161:
155:
131:
130:
123:
116:
109:
105:
102:
96:
74:an advertisement
65:
64:
57:
46:
24:
23:
16:
1014:
1013:
1009:
1008:
1007:
1005:
1004:
1003:
974:
973:
972:
963:
961:
956:
955:
951:
942:
940:
935:
934:
930:
921:
919:
914:
913:
909:
874:
873:
869:
860:
858:
857:on June 4, 2011
848:
847:
843:
831:
829:
828:on June 4, 2011
819:
818:
814:
806:
802:
794:
790:
776:
775:
771:
763:
759:
746:
736:
732:
719:
718:
714:
705:
703:
702:(Press release)
693:
692:
688:
679:
677:
676:(Press release)
667:
666:
662:
655:
651:
641:
639:
630:
629:
625:
616:
614:
605:
604:
600:
590:
588:
583:
582:
578:
569:
567:
550:
549:
545:
541:
514:prostate cancer
492:Health Sciences
480:
455:
427:prostate cancer
366:
328:
317:
306:
305:
304:
299:
288:
282:
279:
269:help improve it
266:
253:
249:
238:
227:
221:
218:
214:higher standard
207:
191:
187:
176:
165:
159:
156:
145:
132:
128:
117:
106:
100:
97:
78:
66:
62:
25:
21:
12:
11:
5:
1012:
1010:
1002:
1001:
996:
991:
986:
976:
975:
971:
970:
949:
928:
907:
867:
841:
812:
800:
788:
769:
757:
730:
712:
686:
660:
649:
623:
598:
576:
542:
540:
537:
479:
476:
454:
451:
372:
371:
368:
367:
365:
364:
361:
357:
355:
351:
350:
341:
335:
334:
330:
329:
326:
319:
318:
301:
300:
256:
254:
247:
240:
239:
194:
192:
185:
178:
177:
135:
133:
126:
119:
118:
89:external links
69:
67:
60:
55:
29:
28:
26:
19:
13:
10:
9:
6:
4:
3:
2:
1011:
1000:
997:
995:
992:
990:
989:Living people
987:
985:
982:
981:
979:
959:
953:
950:
938:
932:
929:
917:
911:
908:
903:
899:
894:
889:
885:
881:
877:
871:
868:
856:
852:
845:
842:
838:
827:
823:
816:
813:
809:
804:
801:
797:
792:
789:
784:
780:
773:
770:
766:
761:
758:
753:
748:|author=
741:
733:
727:
723:
716:
713:
701:
697:
690:
687:
675:
671:
664:
661:
658:
653:
650:
637:
633:
627:
624:
612:
611:simplywall.st
608:
602:
599:
586:
580:
577:
566:
562:
558:
554:
547:
544:
538:
536:
534:
530:
526:
521:
517:
515:
511:
507:
502:
500:
495:
493:
489:
484:
477:
475:
472:
468:
464:
460:
452:
450:
448:
444:
440:
436:
432:
431:schizophrenia
428:
424:
420:
416:
412:
408:
404:
402:
398:
394:
391:
387:
386:life sciences
383:
382:biotechnology
379:
369:
362:
359:
358:
356:
352:
349:
345:
342:
340:
336:
331:
324:
315:
312:
297:
294:
286:
276:
275:
270:
264:
262:
255:
246:
245:
236:
233:
225:
215:
211:
205:
204:
200:
195:This article
193:
184:
183:
174:
171:
163:
153:
149:
143:
141:
140:autobiography
136:This article
134:
125:
124:
115:
112:
104:
94:
90:
86:
82:
76:
75:
70:This article
68:
59:
58:
53:
51:
44:
43:
38:
37:
32:
27:
18:
17:
962:. Retrieved
952:
941:. Retrieved
931:
920:. Retrieved
910:
883:
879:
870:
859:. Retrieved
855:the original
844:
836:
830:. Retrieved
826:the original
815:
803:
791:
783:the original
772:
760:
721:
715:
704:. Retrieved
699:
689:
678:. Retrieved
673:
663:
652:
640:. Retrieved
635:
626:
615:. Retrieved
613:. 2023-02-16
610:
601:
589:. Retrieved
579:
568:. Retrieved
556:
546:
522:
518:
503:
496:
485:
481:
456:
435:fibromyalgia
405:
375:
307:
289:
280:
272:
261:undue weight
258:
228:
219:
196:
166:
157:
137:
107:
98:
83:by removing
79:Please help
71:
47:
40:
34:
33:Please help
30:
984:1955 births
360:Businessman
210:clean it up
978:Categories
964:2011-06-13
943:2011-06-13
922:2011-06-13
861:2010-02-08
832:2010-02-08
706:2010-02-13
680:2010-02-13
642:4 February
617:2023-05-22
591:4 February
570:2023-02-22
539:References
453:Early life
354:Occupation
339:Alma mater
81:improve it
36:improve it
902:216086354
740:cite book
565:0362-4331
443:influenza
407:Medicines
152:talk page
42:talk page
876:"People"
363:investor
283:May 2013
222:May 2013
160:May 2013
101:May 2013
439:obesity
267:Please
208:Please
900:
728:
563:
478:Career
445:, and
419:Canada
415:Mexico
378:doctor
138:is an
898:S2CID
259:lend
752:help
726:ISBN
644:2013
593:2013
561:ISSN
488:NASD
384:and
888:doi
837:D.4
417:or
980::
896:.
884:24
882:.
878:.
835:.
744::
742:}}
738:{{
698:.
672:.
634:.
609:.
559:.
555:.
449:.
441:,
437:,
433:,
403:.
380:,
346:,
45:.
967:.
946:.
925:.
904:.
890::
864:.
754:)
734:.
709:.
683:.
646:.
620:.
595:.
573:.
314:)
308:(
296:)
290:(
285:)
281:(
265:.
235:)
229:(
224:)
220:(
206:.
173:)
167:(
162:)
158:(
154:.
144:.
114:)
108:(
103:)
99:(
95:.
77:.
52:)
48:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.